ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA

被引：0

作者：

Raggi, Chiara ^{[1
]}

Fiaccadori, Karim ^{[2
]}

Pastore, Mirella ^{[1
]}

Correnti, Margherita ^{[2
]}

Piombanti, Benedetta ^{[1
]}

Forti, Elisa ^{[2
]}

Navari, Nadia ^{[1
]}

Abbadessa, Giovanni ^{[3
]}

Hall, Terence ^{[3
]}

Destro, Annarita ^{[2
]}

Di Tommaso, Luca ^{[4
]}

Roncalli, Massimo ^{[5
]}

Meng, Fanyin ^{[6
,7
]}

Glaser, Shannon S. ^{[8
]}

Rovida, Elisabetta ^{[1
]}

Peraldo-Neia, Caterina ^{[9
]}

Olaizola, Paula ^{[10
]}

Banales, Jesus M. ^{[10
]}

Gerussi, Alessio ^{[11
,12
]}

Elvevi, Alessandra ^{[11
,12
]}

Busset, Michele Droz Dit ^{[13
]}

Bhoori, Sherrie ^{[14
]}

Mazzaferro, Vincenzo ^{[15
]}

Alpini, Gianfranco ^{[16
,17
,18
]}

Marra, Fabio ^{[19
]}

Invernizzi, Pietro ^{[20
]}

机构：

[1] Univ Florence, Florence, Italy

[2] Humanitas Clin & Res Ctr, Rozzano, Italy

[3] Arqule Inc, Woburn, MA USA

[4] Humanitas Res Inst, Rozzano, MI, Italy

[5] Humanitas Res Hosp, Pathol Unit, Rozzano, MI, Italy

[6] Richard L Roudebush VA Med Ctr, Div Gastroenterol & Hepatol, Dept Med, Indianapolis, IN USA

[7] Indiana Univ, Bloomington, IN 47405 USA

[8] Texas A&m Hlth Sci Ctr, Bryan, TX USA

[9] Fdn Edo & Elvo Tempia, Canc Genom Lab 8, Biella, Italy

[10] Univ Basque Country UPV EHU, Dept Liver & Gastrointestinal Dis, Biodonostia Res Inst, Donostia Univ Hosp,Ciberehd,Ikerbasque, Leioa, Spain

[11] Univ Milano Bicocca, Div Gastroenterol, San Gerardo Hosp, Dept Med & Surg, Monza, Italy

[12] Univ Milano Bicocca, Ctr Autoimmune Liver Dis, San Gerardo Hosp, Dept Med & Surg, Monza, Italy

[13] Ist Nazl Tumori Irccs Fdn, Hpb Surg & Liver Transplantat, Milan, Italy

[14] Ist Nazl Tumori Irccs Fdn, Gastroenterol & Liver Transplant Hepatol, Milan, Italy

[15] Natl Tumor Inst, Milan, Italy

[16] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA

[17] Indiana Univ, Gastroenterol, Med, Bloomington, IN 47405 USA

[18] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN USA

[19] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy

[20] Univ Milano Bicocca, Dept Med & Surg, Monza, Italy

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

355

引用

页码：226A / 227A

页数：2

共 50 条

[41] Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation
Hall, Terence G.
Yu, Yi
Eathiraj, Sudharshan
Wang, Yunxia
Savage, Ronald E.
Lapierre, Jean-Marc
Schwartz, Brian
Abbadessa, Giovanni
PLOS ONE, 2016, 11 (09):
[42] Significant in Vivo Antitumor Activity by a Highly Potent, Irreversible FGFR Inhibitor, TAS-2985
Nakatsuru, Y.
Fujita, H.
Sootome, H.
Ochiiwa, H.
Ito, K.
Shibata, Y.
Mitsuya, M.
Kazuno, H.
Hirai, H.
Utsugi, T.
EUROPEAN JOURNAL OF CANCER, 2012, 48 : 117 - 117
[43] The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma
Ito, Yoshiro
Yamada, Daisaku
Kobayashi, Shogo
Sasaki, Kazuki
Iwagami, Yoshifumi
Tomimaru, Yoshito
Asaoka, Tadafumi
Noda, Takehiro
Takahashi, Hidenori
Shimizu, Junzo
Doki, Yuichiro
Eguchi, Hidetoshi
CANCER LETTERS, 2024, 595
[44] Development of a novel mouse model for intrahepatic cholangiocarcinoma
Marcus, Rebecca
Foo, Wai Chin
Maitra, Anirban
Gupta, Sonal
CANCER RESEARCH, 2017, 77
[45] CLINICAL CHARACTERISTICS AND PROLIFERATING ACTIVITY OF INTRAHEPATIC CHOLANGIOCARCINOMA
OHASHI, K
NAKAJIMA, Y
TSUTSUMI, M
KANEHIRO, H
FUKUOKA, T
HISANAGA, M
TAKI, J
NAKAE, D
KONISHI, Y
NAKANO, H
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1994, 9 (05) : 442 - 446
[46] Synergistic antitumor activity of futibatinib, an FGFR1-4 inhibitor, and TAS-117, a selective AKT inhibitor, in FGFR-deregulated cancer models
Iwasaki, Junya
Kuramoto, Takuya
Komori, Toshiharu
Saito, Hitoshi
Hirai, Hiroshi
CANCER RESEARCH, 2020, 80 (16)
[47] FGFR2 Alterations in Primary Intrahepatic Cholangiocarcinoma: Driving New Routes for Therapy
Mirchia, Kanish
Gay, Laurie
Elvin, Julia
Vergilio, Jo-Anne
Killian, J. Keith
Nhu Ngo
Ramkissoon, Shakti
Severson, Eric
Hemmerich, Amanda
Chung, Jon
Ali, Siraj
Schrock, Alexa
Reddy, Venkataprasanth
Miller, Vincent
Corona, Robert
Ross, Jeffrey
LABORATORY INVESTIGATION, 2019, 99
[48] FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma
Gentry King
Milind Javle
Current Oncology Reports, 2021, 23
[49] FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma
King, Gentry
Javle, Milind
CURRENT ONCOLOGY REPORTS, 2021, 23 (09)
[50] Intrahepatic cholangiocarcinoma with FGFR alterations: A series of Chinese cases with an emphasis on their clinicopathologic and genetic features
Zhou, Jun
Yu, Haoran
Zeng, Hong
Shen, Qin
Wang, Xuewen
Xia, Qinxin
DIGESTIVE AND LIVER DISEASE, 2024, 56 (12) : 2125 - 2132

← 1 2 3 4 5 →